Archive

Import Regulation And Market of Herbal Medicines In United States of America & Canada

Print

1Pravin Kumar Singh, 2Dr. Vikesh Kumar Shukla, 3Dr. Amrish Chandra

 DOI : http://dx.doi.org/10.31142/ijahm/v11i2.03

1M. Pharm Drug Regulatory Affairs, Amity Institute of Pharmacy, Amity University Noida

2Associate professor, Department of pharmaceutics & Dra, Amity institute of pharmacy, Amity University, l-1 block sector -125, Noida, Uttar Pradesh India

3*Associate Professor, Registered Patent Agent (IN/PA-2959), Govt. of India, Centre for Drug Regulatory Affairs & Pharmacy Practice, Amity Institute of Pharmacy, Amity University l-1 block sector -125, Noida, Uttar Pradesh India

Download Pdf 

Abstract: Herbal medicine was used around the world for many centuries and it is still in use by society quite extensively. Herbal medicines have a very significant role in international trade. Herbal medicine recognition is widely growing around the world on the merit of their clinical, pharmaceutical and economic value. Herbal medicine classification varies from country to country such that in the USA it comes under Dietary supplement and Botanical drugs, Natural Health Product term is used in Canada. In the USA and Canada, Herbal products are mainly used by the younger generation. The present review deals with import regulation requirement of herbal medicine in the USA and Canada. In both countries, it is regulated by USFDA and Health Canada. Herbal medicine market of USA and Canada is growing at a healthy rate. Importers must follow the regulatory requirements of USFDA and Health Canada for fluid marketing approval for their product.

Key word: Herbal medicine, Dietary supplement, Natural health product, USFDA, Health Canada

REFERENCE:

  1. Kumar et al. - Regulations And Challenges Of Herbal Medicines In .pdf [Internet]. [cited 2020 Dec 22]. Available from: https://interscience.org.uk/images/article/v6-i1/15ijahm.pdf
  2. Sen S, Chakraborty R. Revival, modernization and integration of Indian traditional herbal medicine in clinical practice: Importance, challenges and future. J Tradit Complement Med. 2016 Jun 28;7(2):234–44.
  3. HerbalGram: US Sales of Herbal Supplements Increase by 8.6% in 2019 [Internet]. [cited 2020 Oct 26]. Available from: http://cms.herbalgram.org/herbalgram/issue127/hg127-mktrpt-2019.html?ts=1603694912&signature=8bbcca5ac1e14a3d1ddcc32242ba26cd
  4. S. Supplements Industry :75% U.S. adults take dietary supplements [Internet]. Byclue. [cited 2020 Dec 9]. Available from: https://www.byclue.com/nutritional-supplement-overview/us-supplements-industry/
  5. Selling natural health products in Canada [Internet]. Natural Products INSIDER. 2017 [cited 2020 Oct 28]. Available from: https://www.naturalproductsinsider.com/regulatory/selling-natural-health-products-canada
  6. Canada A and A-F. Customized report service – Health and wellness trends in Canada [Internet]. 2019 [cited 2020 Oct 28]. Available from: https://www5.agr.gc.ca/eng/customized-report-service-health-and-wellness-trends-in-canada/?id=1554401656839
  7. pdf [Internet]. [cited 2020 Oct 28]. Available from: https://www.chpcanada.ca/sites/default/files/healthy_growth_final_report.pdf
  8. Nutrition C for FS and A. Dietary Supplement Products & Ingredients [Internet]. FDA. FDA; 2020 [cited 2020 Nov 17]. Available from: https://www.fda.gov/food/dietary-supplements/dietary-supplement-products-ingredients
  9. Research C for DE and. What is a Botanical Drug? FDA [Internet]. 2019 Oct 11 [cited 2020 Nov 17]; Available from: https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/what-botanical-drug
  10. Nutrition C for FS and A. Small Entity Compliance Guide: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements [Internet]. U.S. Food and Drug Administration. FDA; 2020 [cited 2020 Nov 18]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/small-entity-compliance-guide-current-good-manufacturing-practice-manufacturing-packaging-labeling
  11. EUR-Lex - 32004L0024 - EN - EUR-Lex [Internet]. [cited 2020 Nov 27]. Available from: https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX%3A32004L0024
Category: Volume 11 Issue 2 [March-April 2021]